Related Experiment Videos
[Betablockers and skin (author's transl)]
Annales De Dermatologie Et De Venereologie
|November 1, 1979
Summary
Beta-blockers are rarely used in dermatology, but can cause numerous skin reactions. Documenting new cases of beta-blocker-induced cutaneous drug reactions is essential for patient safety.
Area of Science:
- Dermatology
- Pharmacology
Context:
- Beta-blockers are infrequently utilized as dermatological treatments, except for erythermalgia.
- Cutaneous drug reactions represent a significant clinical challenge.
Purpose:
- To review the literature on practolol's cutaneous effects and their underlying mechanisms.
- To highlight the diverse clinical presentations of beta-blocker-induced skin reactions.
Summary:
- Practolol, a beta-blocker, can manifest in various cutaneous conditions.
- While less common, all beta-blockers carry the potential for adverse dermatological side effects.
- Each newly reported instance of a suspected beta-blocker cutaneous reaction warrants thorough evaluation.
Impact:
- Informing dermatologists about the spectrum of potential skin reactions to beta-blockers.
- Emphasizing the need for vigilance and reporting of adverse drug events in dermatology.
- Contributing to a safer therapeutic approach when considering beta-blockers for skin conditions.